QQ客服 官方微博 反馈留言

	Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma
	Ma, Renqiang[1]; Wei, Yi[1]; Huang, Xiaoming[2]; Fu, Ran[1]; Luo, Xi[1]; Zhu, Xiaolin[1]; Lei, Wenbin[1]; Fang, Jugao[3]; Li, Huabin[1]; Wen, Weiping[1]
刊名	PLOS ONE
	2013
卷号	8
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2222501
专题	华南理工大学
作者单位	1.[1]Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Affiliated Hosp 2, Dept Otolaryngol, Guangzhou 510275, Guangdong, Peoples R China 3.[3]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol, Beijing, Peoples R China
推荐引用方式 GB/T 7714	Ma, Renqiang[1],Wei, Yi[1],Huang, Xiaoming[2],et al. Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma[J]. PLOS ONE,2013,8.
APA	Ma, Renqiang[1].,Wei, Yi[1].,Huang, Xiaoming[2].,Fu, Ran[1].,Luo, Xi[1].,...&Wen, Weiping[1].(2013).Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma.PLOS ONE,8.
MLA	Ma, Renqiang[1],et al."Inhibition of GSK 3 beta Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma".PLOS ONE 8(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。